Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest Multiple Myeloma Research Foundation Stories

2011-11-07 15:00:00

SOUTH SAN FRANCISCO, Calif., Nov. 7, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011, at the San Diego Convention Center in San Diego, CA. "The results being presented at ASH demonstrate carfilzomib's potential activity along all lines of multiple myeloma, and we are...

2011-09-20 22:26:59

Multicenter 1000-Patient Trial Initiated to Accelerate Development of Personalized Treatments for Multiple Myeloma The John Theurer Cancer Center at Hackensack University Medical Center, a top 50 U.S. News best hospital for cancer, is one of the first four clinical sites enrolling patients in a landmark study designed to uncover the molecular segments and variations of multiple myeloma. The study is the centerpiece of the Multiple Myeloma Research Foundation´s (MMRF) Personalized...

2011-08-03 15:00:00

SOUTH SAN FRANCISCO, Calif. and NORWALK, Conn., Aug. 3, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the Multiple Myeloma Research Foundation (MMRF) today announced the initiation of an expanded access program for carfilzomib, a selective, next-generation proteasome inhibitor. The Carfilzomib Myeloma Access Program (C-MAP) will include eligible patients in the United States (U.S.) with relapsed and refractory multiple myeloma. Expanded access programs make...

2011-06-25 00:00:30

S. 3988/A. 6233 will ensure that health plans already providing insurance coverage for chemotherapy will provide equal coverage for both IV/injected and oral therapies. The bill will be sent to the governor shortly. New York, NY (PRWEB) June 24, 2011 The New York Assembly voted unanimously 6/22/11 to pass S. 3988/A. 6233, a bill that will eliminate the disparity in insurance coverage between oral and intravenous chemotherapy therapies, ensuring that all cancer patients in the state have...

2011-05-30 00:00:03

Hardy Jones, ocean conservationist, myeloma patient and International Myeloma Foundation (IMF) member, has written a powerful book, The Voice of The Dolphins, highlighting the devastating impact of pollutants on dolphins and our world's oceans.... Bringing in conversations with Dr Brian Durie of the IMF, he makes a compelling argument linking those same toxins to the presence of multiple myeloma in human beings. Los Angeles, California (PRWEB) May 29, 2011 Hardy Jones has written a book...

2011-05-28 00:00:49

The IMF Advocacy team with IMF Volunteer Advocates, made up of patients and caregivers, went to Washington to meet with legislators and staff on May 25th for the One Voice Against Cancer (OVAC) Lobby Day. By sharing their stories and giving a human face to multiple myeloma, they will help insure funding is allocated for critical cancer research and programs that will benefit the myeloma community and all cancer patients. Washington, DC (PRWEB) May 27, 2011 IMF Volunteer Advocates Jan...

2011-05-18 00:01:29

Passage would represent a win for all cancer patients undergoing chemotherapy. Bill sent to governor for signing. Austin, TX (PRWEB) May 17, 2011 HB 438 passed in the State Senate on Tuesday and was sent to the Governor for signing. This bill will eliminate disparity in insurance coverage between oral and intravenous chemotherapy therapies, ensuring that all cancer patients in Texas have access to treatment. Please write to Governor Perry TODAY and ask him to sign HB 438. Oral drug parity...

2011-05-15 00:02:29

Andy Sninsky rode his bicycle 300 miles across the Mojave for multiple myeloma: An IMF FUNdraiser generating hope and raising awareness. (PRWEB) May 14, 2011 Andy Sninsky is a remarkable man. Years ago he rode his bicycle across much of Europe and twice across the United States, but his really extraordinary achievements have just begun. Now, in his early sixties, 3 years out from a diagnosis of Stage III multiple myeloma, he and a co-rider, Tom Moinet, have successfully tackled the grueling...

2011-04-15 00:00:30

Composed of myeloma experts from China, Hong Kong, Taiwan, Japan, Rep. of Korea, Singapore, and Thailand, the IMF Asian Myeloma Network- the first of its kind in the region- will take the lead in projects to assist IMF in providing physician education and patient support throughout Asia. North Hollywood, CA (PRWEB) April 14, 2011 On March 17th the International Myeloma foundation (IMF) established the Asian Myeloma Network (AMN) at a meeting in Singapore. Composed of myeloma experts from...

2011-04-01 15:42:00

WHITE PLAINS, N.Y., April 1, 2011 /PRNewswire/ -- Once again, the Annual Report to the Nation on the Status of Cancer shows a continued decline in diagnoses and deaths for many types of cancers. This encouraging news can be attributed primarily to preventive measures such as cessation of smoking and improved diet, and early detection. (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO ) But for many cancers, such as the blood cancers, early detection is rare, there are no...